Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.

December 31, 2021

Biomarkers for Differential Diagnosis Between Chronic Traumatic Encephalopathy and Alzheimer Disease: A Systematic Review.

Nicholas Kayode Da Silva SoyomboRodrigo Torres
December 17, 2021
Open Access

Assembly of recombinant tau into filaments identical to those of Alzheimer's disease and chronic traumatic encephalopathy

BioRxiv : the Preprint Server for Biology
S. LövestamSjors Scheres
December 9, 2021

A Case of Possible Chronic Traumatic Encephalopathy and Alzheimer's Disease in an Ex-Football Player.

The Neurologist
Arman Fesharaki-Zadeh
December 9, 2021

Structural MRI profiles and tau correlates of atrophy in autopsy-confirmed CTE.

Alzheimer's Research & Therapy
Michael L AloscoJesse Mez
December 6, 2021

Quantifying and Examining Reserve in Symptomatic Former National Football League Players.

Journal of Alzheimer's Disease : JAD
Éimear M FoleyMichael L Alosco
December 3, 2021

Tau phosphorylation sites serine202 and serine396 are differently altered in chronic traumatic encephalopathy and Alzheimer's disease.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
SpiroAnthony StathasThor D Stein
December 1, 2021

Cryo-EM structures of τ filaments from human brain.

Essays in Biochemistry
Michel Goedert
November 27, 2021

The neurological risks of playing association football.

Oliver C CockerellRichard Sylvester
November 26, 2021

Sports psychiatry: a desideratum on sports arena!

CNS Spectrums
Ahmed NaguyBibi Alamiri
November 22, 2021

A review of behavioral methods for the evaluation of cognitive performance in animal models: Current techniques and links to human cognition.

Physiology & Behavior
Maryam GhafarimoghadamMajid Motaghinejad
November 23, 2021
Open Access

Altered Gut Microbial Load and Immune Activation in a Drosophila Model of Human Tauopathy.

Frontiers in Neuroscience
Jerrik RydbomKelly M Lohr
November 18, 2021

Acute Parkinsonism in a Patient with Spinal Cord Injury: A Case Report.

Journal of Neurological Surgery. Part A, Central European Neurosurgery
Francesco PerrottaLea Pia Cantatore
November 3, 2021

Neuropathology of Alzheimer's Disease.

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Jorge A Trejo-LopezStefan Prokop
October 30, 2021

Auditory evoked brain potentials as markers of chronic effects of mild traumatic brain injury in mid-life.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Laura Manning FrankeWilliam C Walker

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved